Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
European Investment Bank
BioCentury | Feb 12, 2022
Finance
Feb. 11 Quick Takes: LSP closes Europe’s largest-ever VC fund at €1 billion
Plus: Regeneron testing high doses of Eylea and updates from the EIB, EdiGene and more
BioCentury | Sep 20, 2021
Finance
Closing Europe’s largest biotech fund at $630M, Jeito readies to build portfolio
French VC gearing up to build portfolio of European companies focused on severe diseases in small patient populations
BioCentury | Feb 18, 2021
Finance
CEO, new support announced for $1 billion AMR Action Fund
The AMR Action Fund named Henry Skinner CEO and announced $140 million in support from philanthropies and the European Commission to supplement the $1 billion previously pledged by 23
BioCentury | Jan 9, 2021
Finance
Closing year with flurry of deals, Tordjman’s Jeito fine-tunes its investment strategy
First investments focus on early-stage European cell and gene therapy
BioCentury | Jul 21, 2020
Deals
As mRNA vaccines gain traction, GSK-CureVac deal aims to advance the modality for future pandemics
BioCentury | Jul 10, 2020
Politics, Policy & Law
Pharmas to invest $1 billion in biotechs to fight AMR as bridge to market reforms
AMR Action Fund pushing antibiotic development but pull mechanisms needed urgently
BioCentury | Jul 10, 2020
Politics, Policy & Law
Bridging the valley of death: a conversation with Thomas Cueni about the AMR Fund
Q&A on the AMR Fund with Thomas Cueni, director general of IFPMA
BioCentury | Jul 6, 2020
Product Development
U.K. may be near 60M dose deal with Sanofi, GSK for second COVID-19 vaccine partnership
Plus €75 million loan for CureVac, Indian approval for Mylan’s remdesivir generic
BioCentury | Jun 26, 2020
Product Development
Pfizer, BioNTech on track to make hundreds of millions of COVID-19 vaccine doses this year
Plus Vaxart’s vaccine selected for Warp Speed preclinical testing, and trio of vaccine manufacturing deals
BioCentury | Jun 17, 2020
Politics, Policy & Law
Momentum builds for equitable procurement of COVID-19 vaccines as EU lays out strategy
EC launches EU-wide procurement strategy to ensure equitable access to COVID-19 vaccines in Europe
Items per page:
1 - 10 of 55